Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Lymphatic Abnormalities × Therapeutics × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Breast Neoplasms 44 Neoplasms 39 Fatigue 29 Depression 25 Prostatic Neoplasms 20 Precursor Cell Lymphoblastic Leukemia-Lymphoma 18 Lymphoma, Follicular 16 Carcinoma, Non-Small-Cell Lung 15 Multiple Myeloma 14 Lymphoma, Large B-Cell, Diffuse 14 Lung Neoplasms 14 Colorectal Neoplasms 14 Pain 13 Lymphoma, Non-Hodgkin 13 Leukemia, Lymphocytic, Chronic, B-Cell 13 Lymphoma, Mantle-Cell 12 Lymphoma, B-Cell, Marginal Zone 12 Leukemia, Myeloid, Acute 12 Hodgkin Disease 12 Burkitt Lymphoma 12 Lymphoma, Large-Cell, Immunoblastic 11 Anxiety Disorders 11 Lymphoma, T-Cell, Cutaneous 10 Leukemia, Myeloid, Chronic-Phase 10 Leukemia, Hairy Cell 10 Blast Crisis 10 Neoplasm Metastasis 9 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 9 Leukemia, Myeloid, Accelerated Phase 9 Head and Neck Neoplasms 9

Interventions

Alpelisib 2 mirdametinib 1 Therapeutics 1 Surgical Procedures, Operative 1 Sclerotherapy 1 Risk Factors 1 Picibanil 1 Injections, Intralesional 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00866827 2019-01-11

Airway Vascular Lesions

University of Arkansas

Hemangioma, Lymphatic Abnormalities

Data powered by HemOnc (CC BY 4.0) Colophon ⚡